LAPAROSCOPIC PELVIC EVISCERATION IN MALE AND FEMALE PATIENTS
https://doi.org/10.38181/2223-2427-2020-1-15-23
Abstract
Abstract: treatment of patients with primary and recurrent locally advanced pelvic tumors represents an extremely complex problem of surgical oncology.
Aim: to evaluate perioperative and long-term postoperative results of laparoscopic pelvic exenteration technique.
Material and methods: in the period from 2011 to 2018, 21 pelvic exenteration was performed with laparoscopic access, (mean age 59.79 ± 8.5), sex distribution: 17 women and 4 men. Nosology distribution: in 6 patients cervical cancer was verified, 7 patients had bladder cancer, 4 patients had rectal cancer, 1 patient had vaginal cancer, 2 patients had recurrence of vaginal cancers after previous uterine extirpation and 1 patient with ovarian neoplasm.
Results: the volume of the exenteration was as follows: 9 total, 7 anterior and 5 posterior. In all cases, it was possible to achieve a negative margin of resection line (R0). The duration of the operation, the volume of blood loss, the frequency and nature of intra- and postoperative complications were evaluated.
Conclusion: laparoscopic access is accompanied by a smaller amount of blood loss, decrease of frequency of early postoperative complications, contributes to more comfortable postoperative period with early activation, less severe pain syndrome and leads to a reduction in the duration of inpatient treatment.
About the Authors
E. A. GalliamovRussian Federation
Galliamov Eduard Abdulhaevich – MD, Professor, Head of the General Surgery Department
Bolshaya Pirogovskaya St., 19/1, 119146, Moscow
M. A. Agapov
Russian Federation
Agapov Mihail Andreevich – MD, Professor of the Department of Surgery
Leninskie Gory St., 1, 119991, Moscow
R. G. Biktimirov
Russian Federation
Biktimirov Rafael Gabbasovich – PhD, head of the Department of Urology
district Novogorsk, Himkinskij city district, 141435
V. P. Sergeev
Russian Federation
Sergeev Vladimir Petrovich – PhD, head of the Department of Oncourology
Marshala Novikova 23, 123098, Moscow
A. E. Sanzharov
Russian Federation
Sanzharov Andrey Evgenevich – PhD, head of the Department of Urology
Orehoviy bulvar, 28, 115682, Moscow
A. D. Kochkin
Russian Federation
Kochkin Aleksey Dmitrievich – PhD, urologist
pr. Lenina 18, 603140, Nizhny Novgorod
D. I. Volodin
Russian Federation
Volodin Denis Igorevich - urologist of the Department of Oncourology
Marshala Novikova 23, 123098, Moscow
P. S. Malahov
Russian Federation
Malahov Pavel Sergeevich - head of the Department of intensive care and anesthesiology of medical research and education center
Leninskie Gory St., 1, 119991, Moscow
G. Yu. Gololobov
Russian Federation
Gololobov Grigoriy Yiryevich - resident of the General Surgery Department
Bolshaya Pirogovskaya St., 19/1, 119146, Moscow
V. V. Kakotkin
Russian Federation
Kakotkin Viktor Viktorovich - Resident of the Department of Surgery
Leninskie Gory St., 1, 119991, Moscow
References
1. American Cancer Society. Cancer Fact & Figures 2017. Atlanta: American Cancer Society; 2017.76 p.
2. Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ. Five-year follow-up of the Medical Research Council CLASSIC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg. 2010, 97, pp. 1638–1645. https://doi.org/10.1002/bjs.7160
3. PelvEx Collaborative. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer. Br J Surg. 2018 May, 105(6), pp. 650-657. https://doi.org/10.1002/bjs.10734
4. Shindo M, Leitao MM, Gardner GJ, Jewell E, Chi DC, AbuRustum NR et al. Local cervical recurrence after radical trachelectomy for early-stage cervical cancer: Is completion hysterectomy necessary? Gynecologic Oncology. 2017, 145, p. 193. https://doi.org/10.1016/j.ygyno.2017.03.440
5. Latypov V.R., Dambaev G. Ts., Popov O.S., Vusik A.N. Results of pelvic exenteration in a woman for cancers and radiotherapy complications Onkourologija. 2015, 1, pp. 55-63. [In Russ]
6. Kostjuk I.P., Shestaev A.Ju. Pelvic evisceration as the method of choice in the treatment of recurrent cervical cancer. Vestnik rossijskoj voenno-medicinskoj akademii. 2012, 1(37), pp. 280-285. [In Russ]
7. Kostyuk I.P., Vasilev L.A., Krestyaninov S.S. Classification of locally advanced pelvic tumors and secondary destruction of the bladder. Onkourologija. 2014, 1, pp. 39-43. [In Russ]
8. Loran O.B., Seregin A.V., Dovlatov Z.A. Late results of treatment and quality of life in women after pelvic exenteration. Onkourologija. 2016, 1, pp. 36-41. [In Russ] https://doi.org/10.17650/1726-9776-2016-12-1-3641
9. Hayashi K, Kotake M, Kakiuchi D, Yamada S, Hada M, Kato Y et al. Laparoscopic total pelvic exenteration using transanal minimal invasive surgery technique with en bloc bilateral lymph node dissection for advanced rectal cancer. Surg Case Rep. 2016. 2(1). C. 74. https://doi.org/10.1186/s40792-016-0198-6
10. Ogura A, Akiyoshi T, Konishi T, Fujimoto Y, Nagayama S, Fukunaga Y et al. Safety of laparoscopic pelvic exenteration with urinary diversion for colorectal malignancies. World J Surg. 2016 May, 40(5), pp. 1236-43. https://doi.org/10.1007/s00268-015-3364-2
11. Quyn AJ, Austin KK, Young JM, Badgery-Parker T, Masya LM, Roberts R et al. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life. Eur J Surg Oncol. 2016 Jun, 42(6), pp. 823-8. https://doi.org/10.1016/j.ygyno.2017.01.014
12. Uehara K, Nakamura H, Yoshino Y, Arimoto A, Kato T, Yokoyama Y et al. Initial experience of laparoscopic pelvic exenteration and comparison with conventional open surgery. Surg Endosc. 2016, 30(1), pp. 132–8. http://dx.doi.org/10.1007/s00464-015-4172-3
13. Rausa E, Kelly ME, Bonavina L, O’Connell PR, Winter DC. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer. Colorectal Dis. 2017, 19(5), pp. 430-436. https://doi.org/10.1111/codi.13647
14. Van der Pas MH, Haglind E, Cuesta MA, Furst A, Lacy AM, Hop WC et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013, 14, pp. 210–218. https://doi.org/10.1016/S1470-2045(13)70016-0
15. Jeong SY, Park JW, Nam BH, Kim S, Kang SB, Lim SB et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol. 2014, 15, pp. 767–774. https://doi.org/10.1016/S14702045(14)70205-0
16. Porpiglia F, Renard J, Billia M, Scoffone C, Cracco C, Terrone C et al. Open versus laparoscopy-assisted radical cystectomy: results of a prospective study. J Endourol. 2007, 21, pp. 325–329. https://doi.org/10.1089/end.2006.0224
17. Vizza E, Pellegrino A, Milani R, Fruscio R, Baiocco E, Cognetti F et al. Total laparoscopic radical hysterectomy and pelvic lymphadenectomy in locally advanced stage IB2-IIB cervical cancer patients after neoadjuvant chemotherapy. Eur J Surg Oncol. 2011, 37, pp. 364–369. https://doi.org/10.1016/j.ejso.2010.12.001
18. Martinez-Gomez C, Angeles MA, Martinez A, Ferron G. Laparoscopic anterior pelvic exenteration in 10 steps. Gynecol Oncol. 2018 Jul, 150(1), pp. 201-202. https://doi.org/10.1016/j.ygyno.2018.04.561
19. Kanao H, Aoki Y, Hisa T, Takeshima N. Total laparoscopic pelvic exenteration for a laterally recurrent cervical carcinoma with a vesicovaginal fistula that developed after concurrent chemoradiotherapy. Gynecol Oncol. 2017 Aug, 146(2), pp. 438-439. http://dx.doi.org/10.1016/j.ygyno.2017.05.030
20. Isla-Ortiz D, Montalvo-Esquivel G, Herrera-Goepfert RE, Herrera-Gomez A, Salcedo-Hernandez RA. Laparoscopic anterior pelvic exenteration in a patient with locally advanced melanoma. Cir Cir. 2017 Dec, 85 Suppl 1, pp. 93-98. https://doi.org/10.1016/j.circir.2016.10.012
21. Aiba T, Uehara K, Tsukushi S, Yoshino Y, Ebata T, Yokoyama Y et al. Perineal alveolar soft part sarcoma treated by laparoscopy‐assisted total pelvic exenteration combined with pubic resection. Asian J Endosc Surg. 2017 May, 10(2), pp. 198-201. 10(2):198-201. https://doi.org/10.1111/ases.12342
22. Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004, 240(2), pp. 205–13. https://doi.org/10.1097/01.sla.0000133083.54934.ae
23. Sidorov D.V., Alekseev B.Ya., Lozhkin M.V., Vorobyev N.V., Petrov L.O., Grishin N.A. et al. 100 small pelvic exenterations in patients with locally advanced primary and recurrent rectal tumors. P.A. Herzen Journal of Oncology. 2017, 6(2), pp. 5-11. https://doi.org/10.17116/onkolog2017625-11 [In Russ]
24. Cibula D, Zikan M, Fischerova D, Kocian R, Germanova A, Burgetova A et al. Pelvic floor reconstruction by modified rectus abdominis myoperitoneal (MRAM) flap after pelvic exenterations. Gynecol Oncol. 2017 Mar, 144(3), pp. 558-563. DOI: 10.1016/j.ygyno.2017.01.014
25. Dessole M, Petrillo M, Lucidi A, Naldini A, Rossi M, De Iaco P et al. Quality of life in women after pelvic exenteration for gynecological malignancies: a multicentric study. Int J Gynecol Cancer. 2018 Feb, 28(2), pp. 267-273. https://doi.org/10.1097/IGC.0000000000000612
Review
For citations:
Galliamov E.A., Agapov M.A., Biktimirov R.G., Sergeev V.P., Sanzharov A.E., Kochkin A.D., Volodin D.I., Malahov P.S., Gololobov G.Yu., Kakotkin V.V. LAPAROSCOPIC PELVIC EVISCERATION IN MALE AND FEMALE PATIENTS. Surgical practice (Russia). 2020;(1):15-23. (In Russ.) https://doi.org/10.38181/2223-2427-2020-1-15-23